MX2023012232A - Ovoproducto hiperinmunizado para tratar o prevenir la enfermedad hepatica alcoholica y la enfermedad de injerto contra huesped. - Google Patents
Ovoproducto hiperinmunizado para tratar o prevenir la enfermedad hepatica alcoholica y la enfermedad de injerto contra huesped.Info
- Publication number
- MX2023012232A MX2023012232A MX2023012232A MX2023012232A MX2023012232A MX 2023012232 A MX2023012232 A MX 2023012232A MX 2023012232 A MX2023012232 A MX 2023012232A MX 2023012232 A MX2023012232 A MX 2023012232A MX 2023012232 A MX2023012232 A MX 2023012232A
- Authority
- MX
- Mexico
- Prior art keywords
- versus
- hyperimmunized
- treating
- enterococcus
- alcoholic liver
- Prior art date
Links
- 208000022309 Alcoholic Liver disease Diseases 0.000 title abstract 3
- 208000009329 Graft vs Host Disease Diseases 0.000 title abstract 2
- 208000024908 graft versus host disease Diseases 0.000 title abstract 2
- 235000013601 eggs Nutrition 0.000 abstract 6
- 241000194033 Enterococcus Species 0.000 abstract 2
- 241000194032 Enterococcus faecalis Species 0.000 abstract 2
- 241000194031 Enterococcus faecium Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 229940032049 enterococcus faecalis Drugs 0.000 abstract 2
- 239000003053 toxin Substances 0.000 abstract 2
- 231100000765 toxin Toxicity 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
En un aspecto, la presente divulgación se dirige a un método para prevenir o tratar la enfermedad hepática alcohólica o la enfermedad de injerto contra huésped en un sujeto que lo necesita, que comprende administrar al sujeto una cantidad terapéuticamente eficaz de un ovoproducto hiperinmunizado obtenido de un animal productor de huevos, previniendo o tratando así la enfermedad hepática alcohólica o la enfermedad de injerto contra huésped en el sujeto, en donde el ovoproducto hiperinmunizado comprende una cantidad terapéuticamente eficaz de uno o más anticuerpos contra un antígeno seleccionado del grupo que consiste en Enterococcus faecalis, toxina citolisina de Enterococcus faecalis y Enterococcus faecium. La presente divulgación también se dirige a huevos hiperinmunizados y ovoproductos producidos por un animal que ha sido hiperinmunizado con un antígeno seleccionado del grupo que consiste en Enterococcus faecalis, toxina citolisina de Enterococcus faecalis aislada y Enterococcus faecium. También se divulgan métodos de preparación de huevos y ovoproductos hiperinmunizados.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163175603P | 2021-04-16 | 2021-04-16 | |
| PCT/US2022/024946 WO2022221616A1 (en) | 2021-04-16 | 2022-04-15 | Hyperimmunized egg product for treating or preventing alcoholic liver disease and graft-versus-host disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023012232A true MX2023012232A (es) | 2023-11-22 |
Family
ID=81926046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023012232A MX2023012232A (es) | 2021-04-16 | 2022-04-15 | Ovoproducto hiperinmunizado para tratar o prevenir la enfermedad hepatica alcoholica y la enfermedad de injerto contra huesped. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240199723A1 (es) |
| EP (1) | EP4322973A1 (es) |
| JP (1) | JP2024522404A (es) |
| KR (1) | KR20230172005A (es) |
| CN (1) | CN117440818A (es) |
| AU (1) | AU2022258701A1 (es) |
| BR (1) | BR112023021345A2 (es) |
| CA (1) | CA3215464A1 (es) |
| CL (1) | CL2023003066A1 (es) |
| CO (1) | CO2023014297A2 (es) |
| IL (1) | IL307440A (es) |
| MX (1) | MX2023012232A (es) |
| WO (1) | WO2022221616A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1014774A2 (pt) * | 2009-04-27 | 2019-04-16 | Immuron Limited | preparacao de imunoglobulina enriquecida anti-lps para uso no tratamento e/ou na profilaxia de um disturbio patologico |
| ES2742734T3 (es) * | 2010-11-23 | 2020-02-17 | Pantheryx Inc | Composiciones y procedimientos para el tratamiento en aplicaciones clínicas de espectro general, no diferenciadas o mixtas |
| US10632158B2 (en) * | 2016-06-23 | 2020-04-28 | IgY Nutrition | Use of a hyperimmune egg product to prevent and treat dysbiosis |
-
2022
- 2022-04-15 US US18/555,338 patent/US20240199723A1/en active Pending
- 2022-04-15 IL IL307440A patent/IL307440A/en unknown
- 2022-04-15 JP JP2023563268A patent/JP2024522404A/ja active Pending
- 2022-04-15 CN CN202280036488.6A patent/CN117440818A/zh active Pending
- 2022-04-15 KR KR1020237039461A patent/KR20230172005A/ko unknown
- 2022-04-15 EP EP22726551.9A patent/EP4322973A1/en active Pending
- 2022-04-15 CA CA3215464A patent/CA3215464A1/en active Pending
- 2022-04-15 MX MX2023012232A patent/MX2023012232A/es unknown
- 2022-04-15 WO PCT/US2022/024946 patent/WO2022221616A1/en active Application Filing
- 2022-04-15 AU AU2022258701A patent/AU2022258701A1/en active Pending
- 2022-04-15 BR BR112023021345A patent/BR112023021345A2/pt unknown
-
2023
- 2023-10-13 CL CL2023003066A patent/CL2023003066A1/es unknown
- 2023-10-25 CO CONC2023/0014297A patent/CO2023014297A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024522404A (ja) | 2024-06-20 |
| CN117440818A (zh) | 2024-01-23 |
| CA3215464A1 (en) | 2022-10-20 |
| KR20230172005A (ko) | 2023-12-21 |
| WO2022221616A1 (en) | 2022-10-20 |
| AU2022258701A1 (en) | 2023-10-26 |
| CO2023014297A2 (es) | 2023-10-30 |
| IL307440A (en) | 2023-12-01 |
| BR112023021345A2 (pt) | 2023-12-19 |
| US20240199723A1 (en) | 2024-06-20 |
| CL2023003066A1 (es) | 2024-05-03 |
| EP4322973A1 (en) | 2024-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210032357A1 (en) | Cd20 binding molecules and uses thereof | |
| DE69530588T2 (de) | Cck-antikörper zur verbesserung der futterverwertung | |
| RU2667432C2 (ru) | Онколитические штаммы clostridium ghonii, способы получения и применения | |
| AR103868A1 (es) | Anticuerpos anti-cd47 como agentes terapéuticos | |
| MX2018009085A (es) | Conjugados de anticuerpos anti-cd74, composiciones que comprenden conjugados de anticuerpos anti-cd74 y metodos de uso de congujados de anticuerpos anti-cd74. | |
| RU2018112649A (ru) | Композиция для лечения рака, объединяющая анти-cd26 антитело и другое противораковое средство | |
| CN105859887A (zh) | 拮抗性抗il-7 受体抗体及方法 | |
| PE20210517A1 (es) | Anticuerpos anti-hla-g y utilizacion de los mismos | |
| CA3103656A1 (en) | Antibodies against disease causing agents of poultry and uses thereof | |
| JP2017534259A5 (es) | ||
| AR085955A1 (es) | Proteinas de union al antigeno | |
| Nagarajan et al. | Monoclonal antibodies for the prevention of rabies: theory and clinical practice | |
| RU2010119450A (ru) | Антитело против bst2 | |
| CN109069630A (zh) | 使用免疫检测点调节剂和共生微生物菌丛的发酵产物的结合癌症疗法 | |
| CA3140739A1 (en) | Antibodies against disease causing agents of poultry and uses thereof | |
| Pakharukova et al. | Similarities and differences among the Opisthorchiidae liver flukes: insights from Opisthorchis felineus | |
| CN104761640A (zh) | 具有中和活性的抗狂犬病病毒单克隆抗体的制备及应用 | |
| MX2023012232A (es) | Ovoproducto hiperinmunizado para tratar o prevenir la enfermedad hepatica alcoholica y la enfermedad de injerto contra huesped. | |
| EP3184120A1 (en) | Emulsified vaccine to obtain formulations of concentrated igy immunoglobulins; processes and uses for the same. | |
| RU2016134909A (ru) | Вакцины на основе реовирусов птиц | |
| Houdebine | Production of human polyclonal antibodies by transgenic animals | |
| DK1165615T3 (da) | Monoklonale antistoffer mod humant protein Mcm3, proces til deres fremstilling af deres anvendelse | |
| JP2004536824A5 (es) | ||
| JP2008169142A (ja) | 食中毒菌に対する抗体の産生方法 | |
| Seida et al. | Hybridomas producing monoclonal antibodies against tetanus toxin replaces the polyclonal horse anti-tetanic serum |